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Hypoxia/reoxygenationBoth calpain activation and endoplasmic reticulum (ER) stress are implicated in ischemic heart injury. However,
the role of calpain in ER stress remains largely elusive. This study investigated whether calpain activation causes
ER stress, thereby mediating cardiomyocyte apoptosis in an in vitro model of hypoxia/re-oxygenation (H/R). In
neonatal mouse cardiomyocytes and rat cardiomyocyte-like H9c2 cells, up-regulation of calpain-1 sufﬁciently
induced ER stress, c-Jun N-terminal protein kinase1/2 (JNK1/2) activation and apoptosis. Inhibition of ER stress
or JNK1/2 prevented apoptosis induced by calpain-1. In an in vitro model of H/R-induced injury in
cardiomyocytes, H/R was induced by a 24-hour hypoxia followed by a 24-hour re-oxygenation. H/R activated
calpain-1, induced ER stress and JNK1/2 activation, and triggered apoptosis. Inhibition of calpain and ER stress
blocked JNK1/2 activation and prevented H/R-induced apoptosis. Furthermore, blockade of JNK1/2 signaling
inhibited apoptosis following H/R. The role of calpain in ER stress was also demonstrated in an in vivo model
of ischemia/reperfusion using transgenic mice over-expressing calpastatin. In summary, calpain-1 induces ER
stress and JNK1/2 activation, thereby mediating apoptosis in cardiomyocytes. Accordingly, inhibition of calpain
prevents ER stress, JNK1/2 activation and apoptosis in H/R-induced cardiomyocytes. Thus, ER stress/JNK1/2
activation may represent an important mechanism linking calpain-1 to ischemic injury.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Ischemic heart disease is the leading cause of death inmost industri-
alized nations as it causes serious complications such as myocardial
infarction (MI). After MI, ischemia-induced myocardial cell death is
followed by a progressive remodeling of the heart [1–3], resulting in a
severe state of compromised heart function known as heart failure.
Heart failure is on the rise as a result of successes in treating acute MI,
and up to 40–50% of people with heart failure die within ﬁve years of
diagnosis [4]. Thus, limiting ischemic injury is extremely important ina/re-oxygenation; I/R, ischemia/
MI, myocardial infarction;MOI,
I-III, calpain inhibitor-III; CAST,
ositol-requiring kinase 1; ATF6,
ation initiation factor 2α; ATF4,
gprotein1;CHOP, thetranscrip-
lasmic reticulumCa2+-ATPase
ies A6-140, 800 Commissioners
6858500x55441; fax: +1 519
n (T. Peng).the prevention of adverse myocardial remodeling and the progression
to heart failure.
Calpains are a family of calcium-dependent thiol-proteases [5]. In
mammals, ﬁfteen gene products of the calpain family have been report-
ed. Among them, calpain-1 (μ-form) and calpain-2 (m-form) are
ubiquitously expressed, and most extensively studied. Calpain-1 and
calpain-2 are heterodimers, consisting of a distinct large 80-kDa catalyt-
ic subunit encoded by the genes capn1 and capn2, respectively, and a
common small 28-kDa regulatory subunit encoded by capn4. They differ
in their calcium requirements for activation (~50 μM for calpain-1 and
~1000 μM for calpain-2). Both calpain-1 and calpain-2 are tightly regu-
lated by calpastatin, an endogenous inhibitor that speciﬁcally inhibits
calpain, but not other cysteine proteases. Over-expression of calpastatin
has been widely used to inhibit calpain in a variety of in vitro [6] and
in vivo models [7,8]. Calpains participate in cardiac patho-physiology.
In cultured cardiomyocytes, we and others demonstrated that calpain-
1 is important in promoting cardiomyocyte apoptosis under various
pathological conditions [9–11]. In response to hypoxia, calpain is acti-
vated and contributes to cardiomyocyte injury [12]. In animal models
of ischemia/reperfusion or MI, both pharmacologic and genetic inhibi-
tions of calpain reduce ischemic cardiac injury, attenuate myocardial
883D. Zheng et al. / Biochimica et Biophysica Acta 1852 (2015) 882–892remodeling and improve myocardial function [13–17]. Furthermore,
transgenic over-expression of calpain-1 is sufﬁcient to induce dilated
cardiomyopathy and heart failure [7]. These previous studies supportFig. 1. Apoptosis and ER stress induced by infection with Ad-capn1. (A–F) Cultured neonatal m
then incubatedwith calpain inhibitor-III (CI-III), TAUR or vehicle. Twenty-four hours later, west
was assessed bymeasuring caspase-3 activity andDNA fragmentation. (A) A representativewes
for capn2 protein from 3 different experiments. (C) Caspase-3 activity. (D) DNA fragmentation.
proteins. (G and H) H9c2 cells were infected with Ad-capn1 or Ad-gal as a control, and then in
caspase-3 activity (G) and DNA fragmentation (H). (I and J) Representative western blots fr
from 3 different experiments. *P b 0.05 vs Ad-gal or Ad-gal + Vehicle and #P b 0.05 vs Ad-capnan important role of calpain in ischemic heart disease [18]. However,
themechanisms relating calpain activation to ischemicmyocardial inju-
ry have not been fully addressed.ouse cardiomyocytes were infected with Ad-capn1, Ad-capn2 or Ad-gal as a control, and
ern blot was performed to analyze capn1, capn2, CHOP and GAPDHproteins, and apoptosis
tern blot for capn1 protein from3 different experiments. (B) A representativewestern blot
(E and F) Representativewestern blots from 3 different experiments for CHOP and GAPDH
cubated with CI-III, TAUR or vehicle. Twenty-four hours later, apoptosis was assessed by
om 3 different experiments for GRP78, CHOP, pPERK and GAPDH. Data are mean ± SD
1 + Vehicle.
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tion of unfold proteins, triggering the unfolded protein response
which activates ER transmembrane sensors to initiate the adaptive
responses [19]. These ER transmembrane sensors include protein
kinase-like ER kinase (PERK), inositol-requiring kinase 1 (IRE1)
and activating transcription factor 6 (ATF6), and their activation re-
sults in phosphorylation of eukaryotic translation initiation factor
2α (eIF2α), translation of transcription factor ATF4, XBP1 splicing,
and ﬁnally the induction of unfolded protein response relatedFig. 2. Role of calpain-1 and ER stress in JNK1/2 activation. (A–C) Cultured neonatal mouse c
incubated with calpain inhibitor-III (CI-III), TAUR or vehicle for 24 h. (A and B) Representat
(C) Representative western blots for SERCA2a from 3 different cultures show that in
were infected with Ad-capn1 or Ad-gal as a control, and then incubated with CI-III, TAUR or v
JNK1/2 and phosphorylated JNK1/2. (F and I) Quantiﬁcation for the ratio of phosphorylated JN
or Ad-gal + Vehicle and #P b 0.05 vs Ad-capn1 + Vehicle.genes including chaperones GRP78 and GRP94, XBP1 and CHOP,
etc. However, in the case of prolonged or overwhelming ER stress,
apoptosis can be induced through CHOP, JNK1/2 and other path-
ways. Recent animal and human studies have revealed that ER
stress-initiated apoptosis is implicated in the pathophysiology of
various cardiovascular diseases, including ischemic heart disease
and heart failure [20,21]. Thus, ER stress may represent an important
therapeutic target for heart diseases [22]. While calpain activation
was shown to correlate with ER stress induction in the hypoxicardiomyocytes were infected with Ad-capn1, Ad-capn2 or Ad-gal as a control, and then
ive western blots for JNK1/2 and phosphorylated JNK1/2 from 3 different experiments.
fection with Ad-capn1 decreases the protein levels of SERCA2a. (D–I) H9c2 cells
ehicle for 24 h. (D and E) Representative western blots from 3 different experiments for
K1/2 over JNK1/2. Data are mean ± SD from 3 different experiments. *P b 0.05 vs Ad-gal
Fig. 3. Effects of TAUR and SP600125 on apoptosis in H9c2 cells. H9c2 cells were infected with Ad-capn1 or Ad-gal as a control, and then incubated with TAUR, SP600125 or
vehicle. Twenty-four hours later, apoptosis was assessed by caspase-3 activity (A and C) and DNA fragmentation (B and D). Data are mean ± SD from 3 different experiments.
*P b 0.05 vs Ad-gal + Vehicle and #P b 0.05 vs Ad-capn1 + Vehicle.
885D. Zheng et al. / Biochimica et Biophysica Acta 1852 (2015) 882–892heart [23], calpain has been reported to disturb Ca2+ homeostasis by
targeting calcium regulatory proteins such as sarco/endoplasmic re-
ticulum Ca2+-ATPase (SERCA) [24] and calcium channel proteins
[25]. As such, they cause the release of ER Ca2+, which may impair
protein processing and thereby promote ER stress [26]. Thus, it is
possible that calpain may play a role in inducing ER stress in ische-
mic heart disease.
In this study, we examined whether calpain-1 activation is
linked to the induction of ER stress in cardiomyocytes, and investi-
gated whether inhibition of calpain prevents ER stress and reduces
cardiomyocyte apoptosis in an in vitro model of hypoxia/re-
oxygenation.Fig. 4.Measurement of calpain activation inH9c2 cells followingH/R. H9c2 cellswere sub-
jected to a 24-hour hypoxia followed by a 24-hour re-oxygenation. (A) Calpain enzymatic
activity was measured in H9c2 cells. Data are mean ± SD from 3 different experiments.
*P b 0.05. (B) is a representative western blot for a 75 kDa active fragment of calpain-1
and (C) for the cleavage of α-spectrin (140 kDa), a natural substrate of calpain-1.2. Materials and methods
2.1. Animals
This investigation conforms to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of Health
(NIH Publication, 8th Edition, 2011). All experimental procedures
were approved by the Animal Use Subcommittee at the University
of Western Ontario, Canada. Breeding pairs of C57BL/6 mice were
purchased from the Jackson Laboratory. Transgenic mice with over-
expression of calpastatin (Tg-CAST) were generously provided by
Dr. Laurent Baud (the Institut National de la Santé et de la Recherche
Médicale, Paris, France) through the European Mouse Mutant Archive.
Mice with cardiomyocyte-speciﬁc disruption of capn4 (capn4-ko)
were generated as described in our recent report [27]. All of the adult
mice used in this study, including controls, were littermates of the
same generation. A breeding program was implemented to produce
neonates at our animal care facilities.
886 D. Zheng et al. / Biochimica et Biophysica Acta 1852 (2015) 882–8922.2. Ischemia/reperfusion (I/R) protocol
Animals were subjected to ischemia for 30min followed by reperfu-
sion for 3 h as we previously described [28,29].Fig. 5. (A–D) Role of calpain in ER stress and JNK1/2 activation following H/R. H9c2 cells were in
hour re-oxygenation. (A) Representative western blots from 3 different experiments for GRP78
for phosphorylated JNK1/2 and JNK1/2. (C and D) Quantiﬁcation for the ratio of phosphorylate
gal+Shamand #P b 0.05 vsAd-gal+H/R. (E–H)Effects of calpain-1 knockdownon ER stress an
1 or control siRNA. Twenty-four hours after transfection, the cells were subjected to H/R. (E
(F) Representative western blots for ER stress markers (GRP78, phosphorylated PERK (pPERK)
calpain-1 reduces H/R-induced ER stress. (G) Caspase-3 activity and (H) DNA fragmentation. D
#P b 0.05 vs H/R + Control siRNA.2.3. Cell culture, adenoviral infection and siRNA transfection
The neonatal mouse cardiomyocytes were prepared and cultured
according to methods we described previously [30].fectedwith Ad-CAST or Ad-gal, and then subjected to a 24-hour hypoxia followed by a 24-
, CHOP, pPERK and GAPDH. (B) Representative western blots from 3 different experiments
d JNK1/2 over JNK1/2. Data are mean ± SD from 3 different experiments. *P b 0.05 vs Ad-
d apoptosis inH9c2 cells followingH/R. H9c2 cellswere transfectedwith siRNA for calpain-
) Representative western blot for capn1 and GAPDH proteins from 3 different cultures.
, CHOP, phosphorylated JNK1/2, and JNK1/2) from 3 different cultures show that silencing
ata are mean ± SD from 3 different experiments. *P b 0.05 vs Sham+ Control siRNA and
887D. Zheng et al. / Biochimica et Biophysica Acta 1852 (2015) 882–892The rat cardiomyocyte-like H9c2 cells were purchased from the
American Type Culture Collection (ATCC) and cultured H9c2 cells
were employed within 10 generations.
Cells were infected with adenoviral vectors containing human
capn1 gene (Ad-capn1, SignaGen Laboratories), human capn2 gene
(Ad-capn2), rat calpastatin gene (Ad-CAST), or beta-gal (Ad-gal, Vector
Biolabs) as a control at a multiplicity of infection (MOI) of 100 PFU/cell.
Adenovirus-mediated gene transferwas implemented as previously de-
scribed [10]. All experiments were performed after 24 h of adenoviral
infection.
Cells were transfected with siRNA speciﬁc for capn1 and capn2
(Santa Cruz Biotechnology, Inc.) using TransMessenger Transfection Re-
agent (Qiagen) as we previously described [11]. A scrambled siRNA
served as a control.
2.4. Hypoxia/re-oxygenation (H/R)
Cardiomyocytes were subjected to a 24-hour period of hypoxia,
followed by re-oxygenation for another 24 h. For the induction of hyp-
oxia, we placed the culture dishes in a sealed chamber containing
GENbag anaer (bioMérieux) for 24 h at 37 °C. Hypoxia was monitored
using anear indicator (bioMérieux). The GENbag anaer rapidly reduces
O2 concentration in chamber within 30 min. Re-oxygenation was
achieved by changing culture media and returning cells to normal
culture conditions. We found that after hypoxia for 3 h the O2 concen-
tration was below 0.1% while pH value in culture media was 7.2 (before
hypoxia pH value was 7.4).
2.5. Calpain activity
Calpain activitieswere determined as described previously [6,10,11].
2.6. Western blot analysis
The protein levels of calpain-1, calpain-2, GRP78, CHOP, ATF6, phos-
phorylated PERK (pPERK), phosphorylated and total JNK1/2, SERCA2aFig. 6. ER stress and apoptosis in capn4-ko cardiomyocytes following H/R. Neonatal cardiomyo
hours after isolation, the cells were subjected to H/R (12-hour hypoxia followed by 6-hour re-o
(B). Data aremean±SD from3different experiments. *P b 0.05 vs Sham+WTand #P b 0.05 vs
show that deletion of capn4 attenuates ER stress in cardiomyocytes following H/R. (D) A repres
protein after H/R.and GAPDHwere determined bywestern blot analysis as previously de-
scribed [6,10,11,15].
2.7. Assessment of apoptosis
Caspase-3 activitywasdeterminedusing a commercial caspase-3 ac-
tivity assay kit as described in our recent report [11].
DNA fragmentation was measured using a Cellular DNA Fragmenta-
tion ELISA kit (Roche Applied Science, Canada) according to the
manufacturer's instructions.
2.8. Statistical analysis
All data were presented as mean ± SD. ANOVA followed by New-
man–Keuls test was performed for multi-group comparisons. A value
of P b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Up-regulation of calpain-1 is sufﬁcient to induce apoptosis, ER stress
and JNK1/2 activation in cardiomyocytes
We have recently demonstrated that calpain-1/2 expression and ac-
tivities are increased in the heart after MI [15]. To examinewhether up-
regulation of calpain-1/2 is sufﬁcient to induce apoptosis, we infected
neonatal mouse cardiomyocytes and rat cardiomyocyte-like H9c2 cells
with Ad-capn1, Ad-capn2 or Ad-gal as a control. Twenty-four hours
later, infection with Ad-capn1 and Ad-capn2 signiﬁcantly elevated the
protein levels of calpain-1 and calpain-2, respectively (Fig. 1A and B).
Up-regulation of calpain-1 induced increases in caspase-3 activation
and DNA fragmentation (Fig. 1C, D, G and H), indicative of apoptosis.
This effect of calpain-1 was inhibited by co-incubation with calpain
inhibitor-III (10 μM) (Fig. 1G and H), suggesting that apoptosis induced
by up-regulation of calpain-1 is due to its enzymatic activity rather than
its protein accumulation. In contrast, up-regulation of calpain-2 did not
induce apoptosis in cardiomyocytes (Fig. 1C and D).cytes were isolated and cultured from capn4-ko mice and their littermates. Twenty-four
xygenation). Apoptosis was determined by caspase-3 activity (A) and DNA fragmentation
H/R+WT. (C) Representativewestern blots for ER stressmarkers from3different cultures
entative western blot for SERCA2a from 3 different cultures shows a reduction in SERCA2a
Fig. 7. Role of ER stress in JNK1/2 activation followingH/R. H9c2 cells were incubatedwith
TAUR or vehicle and then subjected to a 24-hour hypoxia followed by a 24-hour re-
oxygenation. (A) Representative western blots from 3 different experiments for GRP78,
CHOP, pPERK and GAPDH. (B) Representative western blots from 3 different experiments
for phosphorylated JNK1/2 and JNK1/2. (C and D)Quantiﬁcation for the ratio of phosphor-
ylated JNK1/2 over JNK1/2. Data aremean± SD from 3 different experiments. *P b 0.05 vs
Vehicle + Sham and #P b 0.05 vs Vehicle + H/R.
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of ER stress markers including GRP78, CHOP and pPERK. Up-regulation
of calpain-1 increased the protein levels of CHOP, GRP78 and pPERK in
neonatalmouse cardiomyocytes andH9c2 cells,whichwere signiﬁcant-
ly decreased by co-incubation with calpain inhibitor-III (10 μmol/L,
Fig. 1E and I) or ER stress inhibitor, tauroursodeoxycholate (TAUR,
100 μmol/L, Fig. 1F and J). Calpain-1 also increased JNK1/2 phosphoryla-
tion in neonatal mouse cardiomyocytes and H9c2 cells, which was
prevented by calpain inhibitor-III (Fig. 2A, D, F and H) or TAUR
(Fig. 2B, E, G and I). Over-expression of calpain-1 dramatically reduced
the protein levels of SERCA2a in both neonatal mouse cardiomyocytes
(Fig. 2C). However, up-regulation of calpain-2 did not induce ER stress
and JNK1/2 activation (data not shown). Thus, these results provide di-
rect evidence that calpain-1 sufﬁciently induces ER stress, which in turn
activates JNK1/2 in cardiomyocytes. Since both neonatal mouse
cardiomyocytes and H9c2 cells responded to up-regulation of calpain-
1 in a similar way, we used cardiomyocyte-like H9c2 cells for most of
the following studies.
3.2. Inhibition of ER stress and JNK1/2 prevents calpain-1-induced
apoptosis in cardiomyocytes
It is well-known that ER stress promotes apoptosis. We reasoned
that calpain-1-induced apoptosis is mediated through the induction of
ER stress. To examine this hypothesis, we infected H9c2 cells with Ad-
capn1 or Ad-gal, and then incubated themwith TAUR (100 μM). Inhibi-
tion of ER stress prevented caspase-3 activation and DNA fragmentation
induced by calpain-1 up-regulation inH9c2 cells (Fig. 3A and B). This re-
sult supports our hypothesis that induction of ER stress represents an
important mechanism by which calpain-1 induces apoptosis in
cardiomyocytes.
Having shown that inhibition of ER stress prevents JNK1/2 activa-
tion, we hypothesized that JNK1/2 contributed to apoptosis induced
by calpain-1 in cardiomyocytes. To address this hypothesis, we incubat-
ed H9c2 cells with JNK1/2 inhibitor SP600125 (10 μmol/L) after infec-
tion with Ad-capn1 or Ad-gal. SP600125 signiﬁcantly attenuated
caspase-3 activity and reduced DNA fragmentation in Ad-capn1 infect-
ed H9c2 cells (Fig. 3C and D). Taken together, these results support
the view that calpain-induced apoptosis is mediated through the ER
stress/JNK1/2 pathway in H9c2 cells.
3.3. Hypoxia/re-oxygenation (H/R) induces calpain-1 activation, ER stress
and JNK1/2 activation in cardiomyocytes
Both calpain activation and ER stress were induced in the ischemic
heart [15,31]. To determine whether calpain activation plays a role in
ER stress, we infected H9c2 cells with Ad-CAST or Ad-gal as a control,
and then induced H/R on these cells. H/R induced calpain-1 activation
as evidenced by increases in calpain enzymatic activity, active calpain-
1 fragment (75 kDa) and cleaved fragment of α-spectrin (140 kDa)
(Fig. 4A–C). Calpain-1 activation correlatedwith increases in the protein
levels of CHOP, GRP78 and pPERK, indicative of ER stress (Fig. 5A and F),
and JNK1/2 phosphorylation (Fig. 5B–D). These effects of H/R on ER
stress and JNK1/2 activation were signiﬁcantly attenuated by over-
expression of calpastatin (Fig. 5A–D), suggesting an important role of
calpain in ER stress and JNK1/2 activation. However, H/R did not induce
the proteolysis of ATF6 (data not shown). To substantiate the role of
calpain-1 in ER stress and apoptosis, we silenced calpain-1 and
calpain-2 in H9c2 cells using their respective siRNA. Silencing calpain-
1 attenuated H/R-induced ER stress and apoptosis (Fig. 5E–H). In con-
trast, silencing calpain-2 had no effects on ER stress and apoptosis
(data not shown).
To reproduce the role of calpain in primary neonatal cardiomyocytes,
we isolated and cultured neonatal cardiomyocytes from capn4-ko mice
and their wild-type littermates. After hypoxia for 12 h followed by re-
oxygenation for 6 h, apoptosis and ER stress were induced in wild-typecardiomyocytes; however, deletion of capn4 signiﬁcantly reduced
apoptosis and ER stress in capn4-ko cardiomyocytes following H/R
(Fig. 6A–C). H/R also reduced the protein levels of SERCA2a (Fig. 6D).
To study whether ER stress induced JNK1/2 activation, we incubated
H9c2 cells with TAUR (100 μmol/L), an inhibitor of ER stress or vehicle.
After H/R, incubation with TAUR prevented ER stress and JNK1/2 phos-
phorylation (Fig. 7A–D). Thus, these results demonstrate that calpain-1
Fig. 8.Determination of apoptosis in H9c2 cells after H/R. H9c2 cells were infected with Ad-CAST or Ad-gal, or incubatedwith TAUR, SP600125 or vehicle, and then subjected to a 24-hour
hypoxia followed by a 24-hour re-oxygenation. Apoptosis was assessed by measuring caspase-3 activity (A, C, E) and DNA fragmentation (B, D, F). Data are mean ± SD from 3 different
experiments. *P b 0.05 vs Sham + Ad-gal or Sham+ Vehicle and #P b 0.05 vs H/R + Ad-gal or H/R + Vehicle.
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naling in cardiomyocytes.3.4. Inhibition of calpain, ER stress and JNK1/2 prevents apoptosis induced
by H/R
To investigate the role of calpain/ER stress/JNK1/2 signaling in apo-
ptosis, we infected H9c2 cells with Ad-CAST or Ad-gal, or incubated
them with TAUR (100 μmol/L), JNK1/2 inhibitor SP600125 (10 μmol/L)
or vehicle. After H/R, apoptosis was determined. As shown in Fig. 8,
H/R signiﬁcantly increased caspase-3 activity and DNA fragmenta-
tion, whereas inhibition of calpain (Fig. 8A and B), ER stress
(Fig. 8C and D) or JNK1/2 (Fig. 8E and F) prevented such effects.
These results demonstrate that calpain, ER stress and JNK1/2 medi-
ate H/R-induced apoptosis in cardiomyocytes.3.5. Role of calpain in ER stress in an in vivo model of I/R
To examine the role of calpain in ER stress in vivo, I/R protocol was
performed in Tg-CASTmice and their wild-type littermates. I/R resulted
in an increase in calpain activity (Fig. 9A) and induced ER stress inwild-
type mice as determined by increases in GRP78, CHOP and phosphory-
lated JNK1/2; however, the induction of ER stress was signiﬁcantly
attenuated in Tg-CAST mice (Fig. 9B–F). These results conﬁrm that
calpain plays an important role in ER stress in a mouse model of I/R
injury in vivo.4. Discussion
The major ﬁndings of this study are that up-regulation of calpain-1
is sufﬁcient to induce ER stress and apoptosis in cardiomyocytes, and
that inhibition of calpain-1 prevents ER stress and apoptotic cell
death in H/R-stimulated cardiomyocytes. Calpain-1/ER stress mediates
JNK1/2 activation in H/R-stimulated cardiomyocytes. Furthermore,
inhibition of ER stress and JNK1/2 abrogates calpain-1 or H/R-induced
apoptosis. The role of calpain in ER stress is also demonstrated in a
mouse model of I/R-injury. These ﬁndings describe a new mechanism
connecting calpain-1 activation to ischemic injury in cardiomyocytes.
Numerous studies have reported increases in calpain-1/2 expression
and activities in cardiomyocytes following ischemia/re-oxygenation
[32] that contribute to cardiomyocyte apoptosis [9–11]. The up-
regulation of calpain has also been observed in ischemic hearts [15,17,
33]. Both pharmacological calpain inhibitors and genetic inhibition of
calpain reduce acute myocardial injury and improve myocardial func-
tion in animal models of ischemia/reperfusion and MI [13–17]. Our re-
cent study demonstrated that cardiac-speciﬁc deletion of capn4
attenuates myocardial remodeling and heart failure in mice after MI
[15]. These previous studies have indicated the pathophysiological sig-
niﬁcance of calpain activation in ischemic heart disease. The present
study further conﬁrms the detrimental role of calpain-1 in ischemic
cardiomyocytes in vitro. These data suggest that up-regulation of
calpain-1 may directly contribute to the development of heart
failure following ischemia/reperfusion. Indeed, cardiac-speciﬁc over-
expression of calpain-1 was sufﬁcient to induce heart failure in trans-
genic mice [7].
Fig. 9. Effects of calpastatin over-expression on ER stress in an in vivo mouse model of ischemia/reperfusion (I/R). Adult transgenic mice with calpastatin over-expression (Tg-CAST)
and their wild-type littermates (WT) were subjected to an I/R procedure. (A) Calpain activity was measured in heart tissue lysates. Data are mean ± SD, n = 6. *P b 0.05 vs Sham.
(B) Representative western blots for ER stressmarkers from 2 out of 6 hearts in each group. (C–F) Quantiﬁcations for GRP78 (C), CHOP (D), phosphorylated JNK1/JNK1 (E) and phosphor-
ylated JNK2/JNK2 (F). Data are mean ± SD, n = 6. *P b 0.05 vs Sham +WT and #P b 0.05 vs I/R +WT.
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and subsequent heart failure are incompletely understood, but appear
to be multifactorial. Studies using pharmacologic calpain inhibitors
have suggested that the role of calpain in ischemic heart disease may
be associated with impairments of Ca2+ handling proteins [24,25],
cleavages of contractile proteins such as troponin-T and -I [12,34], dis-
ruption of Na+/K+-ATPase activity [33], and release of apoptosis induc-
ing factor and subsequent apoptosis [35]. Calpain is also involved in the
calcineurin/NFAT pathways in response to angiotensin-II [36], which
contributes to myocardial hypertrophy and leads to heart failure after
MI [37]. Recent studies using both calpain-1 transgenic and knockout
mice have shown that calpain-1 mediates proteolytic processing of
PKCα in ischemic myocardium and releases a persistent and constitu-
tively active free catalytic fragment, PKCα-CT. PKCα-CT localizes to nu-
clei and directly promotes nucleo-cytoplasmic shuttling of HDAC5,
which induces expression of apoptosis and other deleterious genes,
leading to heart failure [14,38]. More recently, using cardiac-speciﬁccapn4 knockoutmicewe have reported that up-regulation of calpain in-
duces a reduction of iκB protein and subsequent NF-κB activation. The
NF-κB signaling promotes the pro-inﬂammatory response and inﬁltra-
tion of inﬂammatory cells in infarcted myocardium, which contribute
to myocardial remodeling and heart failure after MI [15]. In the present
study, we provide new evidence in support of the view that calpain-1
induces ER stress in mediating ischemic injury in cardiomyocytes.
First, up-regulation of calpain-1 is sufﬁcient to induce ER stress and ap-
optosis in cardiomyocytes. Second, calpain-1 activation correlates with
the induction of ER stress in H/R-stimulated cardiomyocytes. Third, in-
hibition of calpain prevents ER stress induced by H/R in cardiomyocytes
and by I/R in hearts in vivo. Fourth, inhibition of ER stress protects
cardiomyocytes against H/R- or calpain-1-induced apoptotic cell
death. Furthermore, calpain-1 appeared to activate the PERK and IRE1
branches of the ER stress response in cardiomyocytes. Thus, ER stress
may be an additional mechanism connecting calpain-1 to ischemic
heart injury. It is worthwhile to mention that the present study took a
891D. Zheng et al. / Biochimica et Biophysica Acta 1852 (2015) 882–892combination of calpain-1/2 siRNA, capn4 knockout and calpastatin
over-expression approaches to examine the role of calpain-1 in ER
stress and apoptosis in H/R and I/R-induced injury in cardiomyocytes.
The utilities of capn4 knockout and calpastatin over-expression provid-
ed convincing evidence in support of the involvement of calpain-1/2;
however, these approaches could not identify which isoforms is impor-
tant. Direct knockdown of calpain-1/2 conﬁrmed calpain-1 but not
calpain-2 as a speciﬁc isoform to trigger ER stress in cardiomyocytes fol-
lowing H/R.
The role of calpain in ER stress has also been suggested in non-
cardiomyocytes. For example, calpain-2 was involved in ER stress in
SH-SY5Y cells in response to hypoxia [39] and in renal cell death follow-
ing exposure to reactive chemical toxicants [40]. Pharmacological
inhibition of calpain prevented ER stress in macrophages induced by
Mycobacterium kansasii type strain [41]. However, in the present
study up-regulation of calpain-2 was unable to induce ER stress in
cardiomyocytes. Consistently, silencing calpain-2 did not inhibit ER
stress and apoptosis induced by H/R in cardiomyocytes. Thus, calpain-
2 is not involved in ER stress in cardiomyocytes following H/R. It is
most likely that cardiomyocytes may respond differently from other
cell types upon calpain-2 activation. Yet, what causes this discrepancy
remains unknown.
The IRE1 branch of the ER stress response induces JNK1/2 activation
[19]. Consistently, we show that inhibition of ER stress blocks JNK1/2
signaling in both calpain-1 and H/R-stimulated cardiomyocytes. Impor-
tantly, we demonstrate that ER stress/JNK1/2 signaling mediates apo-
ptosis in cardiomyocytes following H/R. Our observations support a
model whereby calpain-1 activation induces ER stress, which in turn
promotes JNK1/2 signaling, leading to apoptosis in cardiomyocytes suf-
fering ischemic injury. Calpain-1 has also been shown to induce cleav-
age of caspase-12 [42], though whether caspase-12 activation is also
operative downstream of calpain-1/ER stress signaling in ischemia-
initiated apoptosis requires further investigation.
It is well-known that ischemia, oxidative stress and disturbance of
calcium homeostasis usually occur in the heart under stresses, resulting
in the accumulation of unfold proteins. ER stress has been demonstrated
in the ischemic heart [31]; however, it is currently unknown how
calpain-1 mediates ER stress in cardiomyocytes following H/R. The ER
is the main organelle in which free Ca2+ is stored [43]. Disturbance of
Ca2+ homeostasis in the ER lumen inhibits chaperone function and cre-
ates ER stress. The SERCA family resides in the sarcoplasmic reticulum
(SR) within muscle cells. Its main function is the reuptake of Ca2+
from the cytosol into the ER/SR lumen [44]. Thus, inhibition of SERCA
with thapsigargin blocks reuptake of Ca2+ from the cytoplasm, leading
to ER stress [45]. Cardiomyocytes mainly express SERCA2a [44]. In is-
chemic and failing hearts, the protein levels of SERCA2a are signiﬁcantly
reduced [46], which correlate with an increase in calpain activity. Early
studies have suggested that SERCA2a may be a substrate of calpain-1
[24]. Thus, it is possible that up-regulation of calpain-1 activity may in-
duce the proteolytic cleavage of SERCA2a and thereby block reuptake of
Ca2+ from the cytoplasm, leading to ER stress. In fact, our data shows
that both up-regulation of calpain-1 andH/R decrease the protein levels
of SERCA2a in cardiomyocytes. However, we did not detect calpain-1
protein in isolated SR/ER from cardiomyocytes, which is consistent
with a previous report in lung adenocarcinomacells [47]. It is speculated
that calpain-1 may cleave SERCA2a outside of SR/ER.5. Conclusions
This study demonstrates that calpain-1 induces ER stress and subse-
quent JNK1/2 activation, therebymediating apoptosis in cardiomyocytes.
Accordingly, inhibition of calpain prevents ER stress, JNK1/2 activation
and apoptosis in cardiomyocytes following H/R and hearts after I/R.
Thus, this study provides a newmechanismbywhich calpain-1mediates
ischemic injury in cardiomyocytes.Conﬂict of interest
There is no conﬂict of interest.
Acknowledgements
This study was supported by grants from the Canadian Institutes of
Health Research (MOP-133657) and the National Natural Science Foun-
dation of China (81470499), and in part by Western Department of
Medicine Program of Experimental Medicine (POEM) Research Award.
The research in Dr. Guo-Chang Fan's lab is supported by NIH R01 grant
[grant number HL-087861]. T.P. is a recipient of a New Investigator
Award from the Canadian Institutes of Health Research.
References
[1] G.W. Dorn II, Apoptotic and non-apoptotic programmed cardiomyocyte death in
ventricular remodelling, Cardiovasc. Res. 81 (2009) 465–473.
[2] S. Frantz, J. Bauersachs, G. Ertl, Post-infarct remodelling: contribution of wound
healing and inﬂammation, Cardiovasc. Res. 81 (2009) 474–481.
[3] Y. Sun, Myocardial repair/remodelling following infarction: roles of local factors,
Cardiovasc. Res. 81 (2009) 482–490.
[4] Canadian Cardiovascular Society, CCS Consensus Document on Congestive Heart
Failure, 2001.
[5] D.E. Goll, V.F. Thompson, H. Li, W. Wei, J. Cong, The calpain system, Physiol. Rev. 83
(2003) 731–801.
[6] X. Li, Y. Li, L. Shan, E. Shen, R. Chen, T. Peng, Over-expression of calpastatin inhibits
calpain activation and attenuates myocardial dysfunction during endotoxaemia,
Cardiovasc. Res. 83 (2009) 72–79.
[7] A.S. Galvez, A. Diwan, A.M. Odley, H.S. Hahn, H. Osinska, J.G. Melendez, J. Robbins,
R.A. Lynch, Y. Marreez, G.W. Dorn II, Cardiomyocyte degeneration with calpain
deﬁciency reveals a critical role in protein homeostasis, Circ. Res. 100 (2007)
1071–1078.
[8] E. Letavernier, J. Perez, A. Bellocq, L. Mesnard, A. de Castro Keller, J.P. Haymann, L.
Baud, Targeting the calpain/calpastatin system as a new strategy to prevent cardio-
vascular remodeling in angiotensin II-induced hypertension, Circ. Res. 102 (2008)
720–728.
[9] G. Bajaj, R.K. Sharma, TNF-alpha-mediated cardiomyocyte apoptosis involves
caspase-12 and calpain, Biochem. Biophys. Res. Commun. 345 (2006) 1558–1564.
[10] Y. Li, J.M. Arnold, M. Pampillo, A.V. Babwah, T. Peng, Taurine prevents cardiomyocyte
death by inhibiting NADPH oxidase-mediated calpain activation, Free Radic. Biol.
Med. 46 (2009) 51–61.
[11] Y. Li, Q. Feng, M. Arnold, T. Peng, Calpain activation contributes to hyperglycaemia-
induced apoptosis in cardiomyocytes, Cardiovasc. Res. 84 (2009) 100–110.
[12] C. Kositprapa, B. Zhang, S. Berger, J.M. Canty Jr., T.C. Lee, Calpain-mediated proteolyt-
ic cleavage of troponin I induced by hypoxia ormetabolic inhibition in cultured neo-
natal cardiomyocytes, Mol. Cell. Biochem. 214 (2000) 47–55.
[13] Y. Ikeda, L.H. Young, A.M. Lefer, Attenuation of neutrophil-mediated myocardial
ischemia-reperfusion injury by a calpain inhibitor, Am. J. Physiol. Heart Circ. Physiol.
282 (2002) H1421–H1426.
[14] M.Y. Kang, Y. Zhang, S.J. Matkovich, A. Diwan, A.H. Chishti, G.W. Dorn II, Receptor-
independent cardiac protein kinase Calpha activation by calpain-mediated trunca-
tion of regulatory domains, Circ. Res. 107 (2010) 903–912.
[15] J. Ma, M. Wei, Q. Wang, J. Li, H. Wang, W. Liu, J.C. Laceﬁeld, P.A. Greer, M. Karmazyn,
G.C. Fan, T. Peng, Deﬁciency of Capn4 gene inhibits nuclear factor-kappaB (NF-
kappaB) protein signaling/inﬂammation and reduces remodeling after myocardial
infarction, J. Biol. Chem. 287 (2012) 27480–27489.
[16] S.K. Mani, S. Balasubramanian, J.A. Zavadzkas, L.B. Jeffords, W.T. Rivers, M.R. Zile, R.
Mukherjee, F.G. Spinale, D. Kuppuswamy, Calpain inhibition preserves myocardial
structure and function following myocardial infarction, Am. J. Physiol. Heart Circ.
Physiol. 297 (2009) H1744–H1751.
[17] V. Hernando, J. Inserte, C.L. Sartorio, V.M. Parra, M. Poncelas-Nozal, D. Garcia-
Dorado, Calpain translocation and activation as pharmacological targets during
myocardial ischemia/reperfusion, J. Mol. Cell. Cardiol. 49 (2010) 271–279.
[18] D. Garcia-Dorado, M. Ruiz-Meana, J. Inserte, A. Rodriguez-Sinovas, H.M. Piper,
Calcium-mediated cell death during myocardial reperfusion, Cardiovasc. Res. 94
(2012) 168–180.
[19] C. Xu, B. Bailly-Maitre, J.C. Reed, Endoplasmic reticulum stress: cell life and death de-
cisions, J. Clin. Invest. 115 (2005) 2656–2664.
[20] J.G. Dickhout, R.E. Carlisle, R.C. Austin, Interrelationship between cardiac hypertro-
phy, heart failure, and chronic kidney disease: endoplasmic reticulum stress as a
mediator of pathogenesis, Circ. Res. 108 (2011) 629–642.
[21] J. Groenendyk, P.K. Sreenivasaiah, H. Kim do, L.B. Agellon, M. Michalak, Biology of
endoplasmic reticulum stress in the heart, Circ. Res. 107 (2010) 1185–1197.
[22] T. Minamino, I. Komuro, M. Kitakaze, Endoplasmic reticulum stress as a therapeutic
target in cardiovascular disease, Circ. Res. 107 (2010) 1071–1082.
[23] K. Jain, G. Suryakumar, R. Prasad, L. Ganju, Differential activation of myocardial ER
stress response: a possible role in hypoxic tolerance, Int. J. Cardiol. 168 (2013)
4667–4677.
[24] J.P. French, J.C. Quindry, D.J. Falk, J.L. Staib, Y. Lee, K.K. Wang, S.K. Powers, Ischemia-
reperfusion-induced calpain activation and SERCA2a degradation are attenuated by
892 D. Zheng et al. / Biochimica et Biophysica Acta 1852 (2015) 882–892exercise training and calpain inhibition, Am. J. Physiol. Heart Circ. Physiol. 290
(2006) H128–H136.
[25] Z. Pedrozo, G. Sanchez, N. Torrealba, R. Valenzuela, C. Fernandez, C. Hidalgo, S.
Lavandero, P. Donoso, Calpains and proteasomes mediate degradation of ryanodine
receptors in a model of cardiac ischemic reperfusion, Biochim. Biophys. Acta 1802
(2010) 356–362.
[26] M.A. Brostrom, C.O. Brostrom, Calcium dynamics and endoplasmic reticular function
in the regulation of protein synthesis: implications for cell growth and adaptability,
Cell Calcium 34 (2003) 345–363.
[27] Y. Li, J. Ma, H. Zhu, M. Singh, D. Hill, P.A. Greer, J.M. Arnold, E.D. Abel, T. Peng,
Targeted inhibition of calpain reduces myocardial hypertrophy and ﬁbrosis in
mouse models of type 1 diabetes, Diabetes 60 (2011) 2985–2994.
[28] T. Rui, Q. Feng, M. Lei, T. Peng, J. Zhang, M. Xu, E.D. Abel, A. Xenocostas, P.R. Kvietys,
Erythropoietin prevents the acute myocardial inﬂammatory response induced by is-
chemia/reperfusion via induction of AP-1, Cardiovasc. Res. 65 (2005) 719–727.
[29] L. Shan, J. Li, M. Wei, J. Ma, L. Wan, W. Zhu, Y. Li, H. Zhu, J.M. Arnold, T. Peng, Disrup-
tion of Rac1 signaling reduces ischemia-reperfusion injury in the diabetic heart by
inhibiting calpain, Free Radic. Biol. Med. 49 (2010) 1804–1814.
[30] T. Peng, X. Lu, M. Lei, Q. Feng, Endothelial nitric-oxide synthase enhances
lipopolysaccharide-stimulated tumor necrosis factor-alpha expression via cAMP-
mediated p38 MAPK pathway in cardiomyocytes, J. Biol. Chem. 278 (2003)
8099–8105.
[31] A. Azfer, J. Niu, L.M. Rogers, F.M. Adamski, P.E. Kolattukudy, Activation of endoplas-
mic reticulum stress response during the development of ischemic heart disease,
Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1411–H1420.
[32] S. Parameswaran, R.K. Sharma, Altered expression of calcineurin, calpain, calpastatin
and HMWCaMBP in cardiac cells following ischemia and reperfusion, Biochem.
Biophys. Res. Commun. 443 (2014) 604–609.
[33] J. Inserte, D. Garcia-Dorado, V. Hernando, J. Soler-Soler, Calpain-mediated impair-
ment of Na+/K+-ATPase activity during early reperfusion contributes to cell death
after myocardial ischemia, Circ. Res. 97 (2005) 465–473.
[34] X.Y. Lu, L. Chen, X.L. Cai, H.T. Yang, Overexpression of heat shock protein 27 protects
against ischaemia/reperfusion-induced cardiac dysfunction via stabilization of tro-
ponin I and T, Cardiovasc. Res. 79 (2008) 500–508.
[35] Q. Chen, M. Paillard, L. Gomez, T. Ross, Y. Hu, A. Xu, E.J. Lesnefsky, Activation of mi-
tochondrial mu-calpain increases AIF cleavage in cardiac mitochondria during
ischemia-reperfusion, Biochem. Biophys. Res. Commun. 415 (2011) 533–538.[36] N. Burkard, J. Becher, C. Heindl, L. Neyses, K. Schuh, O. Ritter, Targeted proteolysis
sustains calcineurin activation, Circulation 111 (2005) 1045–1053.
[37] F. Panther, T. Williams, O. Ritter, Inhibition of the calcineurin-NFAT signalling cas-
cade in the treatment of heart failure, Recent Pat. Cardiovasc. Drug Discov. 4
(2009) 180–186.
[38] Y. Zhang, S.J. Matkovich, X. Duan, A. Diwan, M.Y. Kang, G.W. Dorn II, Receptor-
independent protein kinase C alpha (PKCalpha) signaling by calpain-generated
free catalytic domains induces HDAC5 nuclear export and regulates cardiac tran-
scription, J. Biol. Chem. 286 (2011) 26943–26951.
[39] C.Y. Wang, J.W. Xie, T. Wang, Y. Xu, J.H. Cai, X. Wang, B.L. Zhao, L. An, Z.Y. Wang,
Hypoxia-triggered m-calpain activation evokes endoplasmic reticulum stress and
neuropathogenesis in a transgenic mouse model of Alzheimer's disease, CNS
Neurosci. Ther. 19 (2013) 820–833.
[40] S. Muruganandan, A.E. Cribb, Calpain-induced endoplasmic reticulum stress and
cell death following cytotoxic damage to renal cells, Toxicol. Sci. 94 (2006)
118–128.
[41] Y.J. Lim, H.H. Choi, J.A. Choi, J.A. Jeong, S.N. Cho, J.H. Lee, J.B. Park, H.J. Kim, C.H. Song,
Mycobacterium kansasii-induced death of murine macrophages involves endoplas-
mic reticulum stress responses mediated by reactive oxygen species generation or
calpain activation, Apoptosis 18 (2013) 150–159.
[42] S. Kumar, V. Kain, S.L. Sitasawad, High glucose-induced Ca2+ overload and oxidative
stress contribute to apoptosis of cardiac cells throughmitochondrial dependent and
independent pathways, Biochim. Biophys. Acta 1820 (2012) 907–920.
[43] D. Mekahli, G. Bultynck, J.B. Parys, H. De Smedt, L. Missiaen, Endoplasmic-reticulum
calcium depletion and disease, Cold Spring Harb. Perspect. Biol. 3 (2011) a004317.
[44] K.F. Frank, B. Bolck, E. Erdmann, R.H. Schwinger, Sarcoplasmic reticulum Ca2+-
ATPase modulates cardiac contraction and relaxation, Cardiovasc. Res. 57 (2003)
20–27.
[45] K. Shimoke, S. Kishi, T. Utsumi, Y. Shimamura, H. Sasaya, T. Oikawa, S. Uesato, T.
Ikeuchi, NGF-induced phosphatidylinositol 3-kinase signaling pathway prevents
thapsigargin-triggered ER stress-mediated apoptosis in PC12 cells, Neurosci. Lett.
389 (2005) 124–128.
[46] M.A. Shareef, L.A. Anwer, C. Poizat, Cardiac SERCA2A/B: therapeutic targets for heart
failure, Eur. J. Pharmacol. 724 (2014) 1–8.
[47] J.L. Hood, W.H. Brooks, T.L. Roszman, Differential compartmentalization of the
calpain/calpastatin network with the endoplasmic reticulum and Golgi apparatus,
J. Biol. Chem. 279 (2004) 43126–43135.
